Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Biomarkers of Alzheimer disease in plasmaMichael C IrizarryEpidemiology (Cambridge, Mass.)|October 10, 2006
Prospective study of plasma folate, vitamin B12, and cognitive function and declineJae Hee Kang, Michael C Irizarry, Francine GrodsteinExperimental Neurology|March 2, 2010
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degenerationAnil Kachroo, Michael C Irizarry, Michael A SchwarzschildThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 15, 2023
Alzheimer's Targeted Treatments: Focus on Amyloid and InflammationTakeshi Iwatsubo, Michael C Irizarry, Joseph W Lewcock, et al.Epilepsy & Behavior : E&B|May 3, 2011
Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsyMarianne C Cunnington, David J Webb, Michael C Irizarry, et al.Archives of Neurology|September 12, 2002
Beta-secretase protein and activity are increased in the neocortex in Alzheimer diseaseHiroaki Fukumoto, Bonnie S Cheung, Bradley T Hyman, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentErica Andreozzi, Steven Hersch, Michelle Gee, et al.The Journal of Biological Chemistry|October 18, 2002
Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levelsHiroaki Fukumoto, Amy Deng, Michael C Irizarry, et al.Neuroscience Letters|August 28, 2004
Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's diseaseMartin Ingelsson, Jennifer Jesneck, Michael C Irizarry, et al.Journal of Neuropathology and Experimental Neurology|April 7, 2007
Plasma Abeta levels do not reflect brain Abeta levelsStefanie H Freeman, Susan Raju, Bradley T Hyman, et al.Pageof 8